Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

Newsletter Archive

If you would like to receive our newsletters regularly, please click here or send us an email to the following address: info@dr-rath-foundation.org

September 25, 2009

Latest News Updates

Keep up-to-date on the latest health and politics news with our regular updates and analysis of the key stories from around the world.

Natural Health News

September 21, 2009

Vitamin D 'helps combat cancer'
Vitamin D can improve the survival chances of both skin and bowel cancer patients, research has shown. Two studies showed that patients with higher levels of the vitamin in their blood when they were diagnosed were less likely to die from their disease. US scientists from the Dana-Farber Cancer Institute in Boston monitored the progress of 1,017 bowel cancer patients for around nine years. They found that patients with higher blood levels of vitamin D at diagnosis were 50% less likely to die during that time than those with lower levels.
Read Press Association news report at google.com

September 21, 2009

Can an over-the-counter vitamin-like substance slow the progression of Parkinson's disease?
Rush University Medical Center is participating in a large-scale, multi-center clinical trial in the U.S. and Canada to determine whether a vitamin-like substance, in high doses, can slow the progression of Parkinson's disease, a neurodegenerative disorder that affects about one million people in the United States. "At present, the very best therapies we have for Parkinson's can only mask the symptoms - they do not alter the underlying disease," said neurologist Dr. Katie Kompoliti, a specialist in movement disorders. "Finding a treatment that can slow the degenerative course of Parkinsons's is the holy grail of Parkinson's research." The substance being tested, called coenzyme Q10, is produced naturally in the body and is an important link in the chain of chemical reactions that produce energy in mitochondria, the "powerhouses" of cells.
Read article at physorg.com
Comment: Research has shown that Parkinson's patients have impaired mitochondrial function and low levels of coenzyme Q10 and, moreover, that the vitamin-like substance can protect the area of the brain damaged in Parkinson's.

September 17, 2009

Omega-3 may improve blood pressure in kidney disease patients
A combination of omega-3 fatty acids and coenzyme Q10 (CoQ10) may decrease blood pressure and heart rate in kidney disease patients, says a new study. People with chronic kidney disease (CKD), which increases the risk of heart disease two- to 50-fold, experienced improvements in both blood pressure and heart rate following supplementation with four grams of omega-3 fatty acids, according to findings published in the Journal of Hypertension. Furthermore, when taken in combination with coenzyme Q10 the blood pressure reducing benefits were enhanced, despite CoQ10 alone not being associated with any improvements on its own, report researchers from University of Western Australia and Royal Perth Hospital.
Read article at nutraingredients.com
Comment: The effect upon blood pressure obtained by combining coenzyme Q10 with omega-3 fatty acids is an example of nutrient synergy. The concept of nutrient synergy maximizes the health benefits of micronutrients because of the discovery that they work best in "teams". Thus, it is not the intake of any one single nutrient that ensures full health, but the intake of a complete spectrum of various different micronutrients, such as vitamins, minerals, amino acids and trace elements. Dr. Rath, Dr. Niedzwiecki and their researchers at the Dr. Rath Research Institute have focused their attention on nutrient synergy as the most effective approach to optimizing cellular metabolism and restoring its balance, and have repeatedly shown that this approach is more effective than using individual nutrients, or their random combination. To read about clinical studies conducted by the Dr. Rath Research Institute that utilize nutrient synergy, click here.

For more natural health news, click here.

See also our 2001-2008 news archive, by clicking here.

Pharma "Business with Disease" News

September 22, 2009

Paxil Side Effects Linked to Birth Defects in 2001 According to Trial Testimony
Testimony from GlaxoSmithKline officials suggest that the drug company knew that side effects of Paxil could cause birth defects as early as 2001, lending some support to claims that the company suppressed or downplayed the drugs’ birth defect risks. The revelations came during the first trial out of about 600 product liability lawsuits pending against Glaxo over the Paxil birth defect risks, which allege that the company hid test data and failed to adequately warn about the increased risk of persisitent pulmonary hypertension in newborns (PPHN) and other heart problems when the drug is used during pregnancy.
Read article at aboutlawsuits.com (USA)

September 20, 2009

When stories extol drugs, maker may be behind it
Documents recently released in federal court cases against the drug company Wyeth have exposed one of the dirty secrets in the world of medical journals: the widespread practice of ghostwriting. While doctors are named as the authors of articles about treatments and diseases, behind the scenes is a paid writer who is largely responsible for crafting the piece. Not only is the ghostwriter on the payroll of a drug company with interests in the topic, the company often reviews the manuscript before the physician sees it.
Read article in the St. Petersburg Times (Florida/USA)

September 18, 2009

British doctor faces action over claims of 'ghost writing' for US drug company
Doctors have been agreeing to be named as authors on studies written by employees of the pharmaceutical industry, giving greater credibility to medical research, according to new evidence. The Guardian has learned that one of Britain's leading bone specialists is facing disciplinary action over accusations that he was involved in "ghost writing".
Read article in the Guardian (UK)
Comment: The UK’s General Medical Council will call Professor Richard Eastell in front of a fitness to practice committee. Eastell, a bone expert at Sheffield University, has admitted he allowed his name to go forward as first author of a study on an osteoporosis drug even though an employee of Proctor and Gamble, the US company making Actonel, was the only author who had all the figures.

September 15, 2009

Glaxo Executive’s Memo Suggested Burying Drug Studies
An executive of GlaxoSmithKline Plc, the world’s second-biggest drugmaker, talked about burying negative studies linking its antidepressant drug Paxil to birth defects, according to a company memo introduced at a trial.
Read article at bloomberg.com

September 8, 2009

Ghostwriting: The Dirty Little Secret of Medical Publishing That Just Got Bigger
If you are an editor, author, reviewer, or reader of medical journals, or if you depend on your doctor or health care provider getting unbiased information from medical journals, then the 1,500 documents now hosted on the PLoS Medicine Web site should make you very concerned and angry. Because, quite simply, the story told in these documents amounts to one of the most compelling expositions ever seen of the systematic manipulation and abuse of scholarly publishing by the pharmaceutical industry and its commercial partners in their attempt to influence the health care decisions of physicians and the general public.
Read article on the Public Library of Science (PLoS) website

For more pharma "business with disease" news, click here.

See also our 2001-2008 news archive, by clicking here.

Other Health-related News

September 21, 2009

Insufficient levels of vitamin D puts elderly at increased risk of dying from heart disease
A new study by researchers at the University of Colorado Denver and Massachusetts General Hospital (MGH) shows vitamin D plays a vital role in reducing the risk of death associated with older age. The research, just published in the Journal of the American Geriatrics Society, evaluated the association between vitamin D levels in the blood and the death rates of those 65 and older. The study found that older adults with insufficient levels of vitamin D die from heart disease at greater rates that those with adequate levels of the vitamin.
Read article at physorg.com

September 18, 2009

Vitamin insufficiency may accelerate age-related diseases
Current recommendations for vitamin K are not being met, placing people at increased risk of age-related diseases such as cancer and heart disease, says a new analysis. A new analysis of data from hundreds of published articles dating back to the 1970's by Joyce McCann, PhD, and Bruce Ames, PhD, from Children's Hospital Oakland Research Institute also suggests that current recommendations for vitamin K intakes need to be increased to ensure optimal health.
Read article at nutraingredients-usa.com

September 16, 2009

Current vitamin D doses insufficient for mothers-to-be
Many mothers to be are not getting enough vitamin D, even those taking supplements at the recommended doses, says a new study from Northern Ireland. Almost all of the women in the study had blood levels of the vitamin below 80 nmol/l, a level which is widely considered to be the cut-off for vitamin D sufficiency, showing that current recommendations may be insufficient.
Read article at nutraingredients.com

September 16, 2009

Swimming pool chlorine linked to child asthma
Children who spend a lot of time swimming in chlorinated pools could be up to eight times as likely to develop asthma and other allergies. And the chemical can increase the risk even more than second hand smoke, researchers found. Scientists compared the health of 733 teenagers who swam in pools disinfected with chlorine with 114 who swam in pools treated with a copper-silver mix. They found that among those susceptible to developing allergies – about half of all children – those who spent 100 hours or more in chlorinated pools were up to six times as likely to develop asthma than others.
Read article in the Daily Express (UK)

For more health-related news, click here.

See also our 2001-2008 news archive, by clicking here.

Political News

September 19, 2009

EU funding 'Orwellian' artificial intelligence plan to monitor public for "abnormal behaviour"
The European Union is spending millions of pounds developing "Orwellian" technologies designed to scour the internet and CCTV images for "abnormal behaviour". A five-year research programme, called Project Indect, aims to develop computer programmes which act as "agents" to monitor and process information from web sites, discussion forums, file servers, peer-to-peer networks and even individual computers.
Read article in the Daily Telegraph (UK)
Comment: Unless the Lisbon Treaty is rejected, this is the direction in which the EU is headed. To sign the online petition rejecting the Lisbon Treaty, click here. To learn about the dark roots of the “Brussels EU”, click here.

September 16, 2009

The most important election in Europe, but the voters are not invited
Europe has just held its most significant election since 2004: more important than Tony Blair’s re-election, or Nicolas Sarkozy’s victory, and vastly more important than the coming poll in Germany. What? You hadn’t heard? Perhaps that’s because only 736 people were invited to participate. José Manuel Durão Barroso has just been re-elected President of the European Commission. Since Brussels now generates, depending on whose figures we believe, between 55 and 84 per cent of all the legislation in the member states, and since the European Commission is the only EU institution allowed to propose laws, I’d say that makes him the most powerful man in Europe. Yet the entirety of his mandate resides in a lacklustre secret ballot among Euro-MPs, who have just approved his reappointment by 382 votes to 219, with 117 abstentions.
Read Daniel Hannan's blog entry on the Daily Telegraph website (UK)
Comment: Far from being a democracy, the EU is essentially now a dictatorship. With Barroso’s re-election having been fixed up in advance by the leaders of the 27 member states during the summer recess, and ordinary citizens having no say whatsoever in the process, he was presented to the European Parliament with no alternative on offer and a majority of the votes already fixed. To learn the true facts about the EU, click here.

September 10, 2009

Brussels in 'frightening' grab for personal information
Civil liberties and privacy are being eroded at a "breathtaking" rate by European Union governments, according to a report. Civil liberties watchdog Statewatch criticised the EU's post-9/11 security strategy as a "frightening" grab for every aspect of individual information. The 60-page report - published on the seventh anniversary of the terrorist attacks on New York and Washington - said that the EU now saw data privacy and judicial scrutiny of police surveillance tactics as obstacles to efficient law enforcement co-operation, rather than rights to be safeguarded.
Read article in the Daily Telegraph (UK)
Comment: To read the Statewatch report, click here.

For more political news, visit the news pages on the website of the International Alliance for Health, Peace and Social Justice, and the news page on the European Referendum Initiative website.

Back to the Newsletter Archive…